Health Care & Life Sciences » Pharmaceuticals | Hutchison China MediTech Ltd.

Hutchison China MediTech Ltd. | Ownership

Companies that own Hutchison China MediTech Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Slater Investments Ltd.
1,813,926
2.73%
-433,790
11.84%
10/18/2017
FIL Investment Management (Hong Kong) Ltd.
1,631,009
2.45%
-73,811
0.43%
05/31/2018
Hargreave Hale Ltd.
485,000
0.73%
-11,401
0.3%
03/29/2018
M&G Investment Management Ltd.
252,050
0.38%
-371,313
0.02%
06/30/2018
Harvest Global Investments Ltd.
141,587
0.21%
141,587
0.43%
12/31/2017
Standard Life Investments Ltd.
132,622
0.2%
4,891
0.01%
08/31/2018
Artemis Investment Management LLP
130,000
0.2%
-20,000
0.03%
06/29/2018
T. Rowe Price International Ltd.
88,299
0.13%
14,835
0.01%
06/30/2018
APG Asset Management NV
65,753
0.1%
77
0%
03/31/2018
Schroder Investment Management (Hong Kong) Ltd.
55,053
0.08%
0
0.02%
11/30/2017

About Hutchison China MediTech

View Profile
Address
Cheung Kong Center
Hong Kong
Hong Kong
Employees -
Website http://www.chi-med.com
Updated 07/08/2019
Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.